ProShare Advisors’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $98.3K | Sell |
10,435
-2,569
| -20% | -$28.2K | ﹤0.01% | 1709 |
|
|
2025
Q4 | $162K | Buy |
13,004
+370
| +3% | +$4.92K | ﹤0.01% | 1782 |
|
|
2025
Q3 | $181K | Sell |
12,634
-2,332
| -16% | -$31.9K | ﹤0.01% | 1715 |
|
|
2025
Q2 | $184K | Sell |
14,966
-941
| -6% | -$13.7K | ﹤0.01% | 1745 |
|
|
2025
Q1 | $350K | Sell |
15,907
-4,454
| -22% | -$105K | ﹤0.01% | 1307 |
|
|
2024
Q4 | $462K | Buy |
20,361
+6,266
| +44% | +$137K | ﹤0.01% | 1316 |
|
|
2024
Q3 | $256K | Buy |
+14,095
| New | +$327K | ﹤0.01% | 1577 |
|
|
2023
Q2 | – | Sell |
-4,707
| Closed | -$270K | – | 1873 |
|
|
2023
Q1 | $270K | Sell |
4,707
-871
| -16% | -$49.1K | ﹤0.01% | 1265 |
|
|
2022
Q4 | $313K | Buy |
5,578
+449
| +9% | +$22.9K | ﹤0.01% | 1217 |
|
|
2022
Q3 | $217K | Buy |
5,129
+29
| +0.6% | +$1.49K | ﹤0.01% | 1351 |
|
|
2022
Q2 | $275K | Sell |
5,100
-2,153
| -30% | -$129K | ﹤0.01% | 1261 |
|
|
2022
Q1 | $466K | Sell |
7,253
-1,150
| -14% | -$75.7K | ﹤0.01% | 1324 |
|
|
2021
Q4 | $564K | Buy |
8,403
+1,658
| +25% | +$112K | ﹤0.01% | 1362 |
|
|
2021
Q3 | $462K | Sell |
6,745
-1,188
| -15% | -$83.9K | ﹤0.01% | 1250 |
|
|
2021
Q2 | $541K | Buy |
7,933
+1,149
| +17% | +$81.3K | ﹤0.01% | 1477 |
|
|
2021
Q1 | $469K | Sell |
6,784
-31
| -0.5% | -$2.1K | ﹤0.01% | 1486 |
|
|
2020
Q4 | $442K | Buy |
6,815
+812
| +14% | +$43.7K | ﹤0.01% | 1345 |
|
|
2020
Q3 | $283K | Buy |
6,003
+205
| +4% | +$9.75K | ﹤0.01% | 1217 |
|
|
2020
Q2 | $272K | Buy |
+5,798
| New | +$285K | ﹤0.01% | 1281 |
|
|
2020
Q1 | – | Sell |
-7,742
| Closed | -$451K | – | 1356 |
|
|
2019
Q4 | $451K | Buy |
7,742
+733
| +10% | +$43.6K | ﹤0.01% | 1120 |
|
|
2019
Q3 | $421K | Sell |
7,009
-351
| -5% | -$20.9K | ﹤0.01% | 1044 |
|
|
2019
Q2 | $411K | Sell |
7,360
-1,330
| -15% | -$68.5K | ﹤0.01% | 1095 |
|
|
2019
Q1 | $484K | Buy |
8,690
+1,922
| +28% | +$97.9K | ﹤0.01% | 1031 |
|
|
2018
Q4 | $305K | Sell |
6,768
-1,561
| -19% | -$85.6K | ﹤0.01% | 1140 |
|
|
2018
Q3 | $549K | Buy |
8,329
+644
| +8% | +$40K | ﹤0.01% | 1065 |
|
|
2018
Q2 | $495K | Sell |
7,685
-4,050
| -35% | -$251K | ﹤0.01% | 1124 |
|
|
2018
Q1 | $649K | Sell |
11,735
-1,358
| -10% | -$71.2K | ﹤0.01% | 995 |
|
|
2017
Q4 | $627K | Buy |
13,093
+5,979
| +84% | +$293K | ﹤0.01% | 1025 |
|
|
2017
Q3 | $359K | Buy |
7,114
+767
| +12% | +$39.4K | ﹤0.01% | 1077 |
|
|
2017
Q2 | $346K | Sell |
6,347
-2,003
| -24% | -$95.6K | ﹤0.01% | 1097 |
|
|
2017
Q1 | $352K | Sell |
8,350
-2,692
| -24% | -$115K | ﹤0.01% | 1172 |
|
|
2016
Q4 | $474K | Buy |
11,042
+3,888
| +54% | +$158K | 0.01% | 1105 |
|
|
2016
Q3 | $295K | Sell |
7,154
-1,542
| -18% | -$64.6K | ﹤0.01% | 1156 |
|
|
2016
Q2 | $347K | Buy |
8,696
+432
| +5% | +$15.5K | ﹤0.01% | 1141 |
|
|
2016
Q1 | $278K | Sell |
8,264
-1,426
| -15% | -$44.4K | ﹤0.01% | 1239 |
|
|
2015
Q4 | $328K | Buy |
+9,690
| New | +$303K | ﹤0.01% | 1242 |
|
|
2015
Q3 | – | Sell |
-9,032
| Closed | -$249K | – | 1497 |
|
|
2015
Q2 | $249K | Sell |
9,032
-4,428
| -33% | -$118K | ﹤0.01% | 1387 |
|
|
2015
Q1 | $339K | Sell |
13,460
-1,097
| -8% | -$25.9K | ﹤0.01% | 1395 |
|
|
2014
Q4 | $323K | Sell |
14,557
-11,129
| -43% | -$226K | ﹤0.01% | 1468 |
|
|
2014
Q3 | $521K | Sell |
25,686
-6,206
| -19% | -$124K | 0.01% | 1381 |
|
|
2014
Q2 | $613K | Sell |
31,892
-26,026
| -45% | -$485K | 0.01% | 1455 |
|
|
2014
Q1 | $1.09M | Buy |
+57,918
| New | +$1.12M | 0.01% | 1233 |
|
|
2013
Q4 | – | Sell |
-32,068
| Closed | -$528K | – | 1588 |
|
|
2013
Q3 | $528K | Sell |
32,068
-817
| -2% | -$13.1K | 0.01% | 1422 |
|
|
2013
Q2 | $492K | Buy |
+32,885
| New | +$482K | 0.01% | 1339 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
ProShare Advisors's IART Position: Q1 2026 in Review
ProShare Advisors reduced its Integra LifeSciences (IART) stake by 20% in Q1 2026, selling an estimated $28.2K and leaving 10,435 shares worth $98.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.
ProShare Advisors first reported a position in IART in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.09M in Q1 2014. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- ProShare Advisors held 10,435 shares of Integra LifeSciences worth $98.3K as of Q1 2026.
- ProShare Advisors sold 2,569 Integra LifeSciences shares in Q1 2026, an estimated $28.2K.
- Integra LifeSciences made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1709 holding.
- ProShare Advisors first reported a position in Integra LifeSciences in Q2 2013 and has held it in 44 quarters since.
- ProShare Advisors's Integra LifeSciences position peaked at $1.09M in Q1 2014.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.